{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:43:20Z","timestamp":1787784200072,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.preghy.2019.05.015","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T11:57:07Z","timestamp":1558094227000},"page":"178-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6952-9955","authenticated-orcid":false,"given":"Ashish","family":"Premkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie M.","family":"Dude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10022","key":"10.1016\/j.preghy.2019.05.015_b0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"issue":"5957","key":"10.1016\/j.preghy.2019.05.015_b0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.1.5957.548","article-title":"Pre-eclampsia in pregnancies by different fathers: immunological studies","volume":"1","author":"Need","year":"1975","journal-title":"BMJ"},{"issue":"9340","key":"10.1016\/j.preghy.2019.05.015_b0015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.preghy.2019.05.015_b0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jri.2007.04.005","article-title":"Is pre-eclampsia less common in patients with HIV\/AIDS?","volume":"76","author":"Hall","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.preghy.2019.05.015_b0025","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach","author":"World Health Organization (WHO)","year":"2013"},{"key":"10.1016\/j.preghy.2019.05.015_b0030","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV: Department of Health and Human Services (HHS); 2017 [updated 17 October 2017. Available from: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf."},{"issue":"3","key":"10.1016\/j.preghy.2019.05.015_b0035","doi-asserted-by":"crossref","first-page":"315.e1","DOI":"10.1016\/j.ajog.2009.06.017","article-title":"Obstetric and newborn infant outcomes in human immunodeficiency virus\u2013infected women who receive highly active antiretroviral therapy","volume":"201","author":"Haeri","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1701-2163(16)35156-8","article-title":"Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study","volume":"34","author":"Boyajian","year":"2012","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.preghy.2013.11.008","article-title":"Pre-eclampsia and gestational hypertension are less common in HIV infected women","volume":"4","author":"Hall","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"9354","key":"10.1016\/j.preghy.2019.05.015_b0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(03)12359-8","article-title":"Effects of antiretroviral therapy on occurrence of pre-eclampsia","volume":"361","author":"Mawson","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijgo.2015.08.007","article-title":"A systematic review of the effect of HIV infection and antiretroviral therapy on the risk of pre-eclampsia","volume":"133","author":"Adams","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0000000000000686","article-title":"HIV, Antiretroviral therapy, and hypertensive disorders in pregnancy: a systematic review and meta-analysis","volume":"70","author":"Browne","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajog.2007.07.040","article-title":"Maternal infection and risk of preeclampsia: systematic review and metaanalysis","volume":"198","author":"Conde-Agudelo","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.preghy.2019.05.015_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074848","article-title":"HIV and the risk of direct obstetric complications: a systematic review and meta-analysis","volume":"8","author":"Calvert","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.preghy.2019.05.015_b0075","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0000000000001424","article-title":"Risk of preeclampsia in human immunodeficiency virus-infected pregnant women","volume":"127","author":"Sansone","year":"2016","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.preghy.2019.05.015_b0080","unstructured":"A. Premkumar, A. Dude, L. Haddad, L. M. Yee. The risk of hypertensive disorders of pregnancy among HIV-positive women receiving anti-retroviral therapy: PROSPERO CRD42017078838; 2017 [Available from: http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD42017078838."},{"key":"10.1016\/j.preghy.2019.05.015_b0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2019.05.015_b0090","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions, in: J. Higgins, S. Green (Ed.), Cochrane Collaboration; 2011."},{"key":"10.1016\/j.preghy.2019.05.015_b0095","unstructured":"U.S. Preventative Task Force. U.S. Preventative Task Force Ratings 2013 [Available from: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/us-preventive-services-task-force-ratings."},{"key":"10.1016\/j.preghy.2019.05.015_b0100","unstructured":"American College of Obstetricians and Gynecologists (ACOG) Task Force on Hypertension in Pregnancy. Hypertension In Pregnancy. Washington D.C.: American College of Obstetricians and Gyncologists, 2013."},{"key":"10.1016\/j.preghy.2019.05.015_b0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4236\/wjcd.2014.45034","article-title":"HIV infection in pregnancy and the risk of gestational hypertension and preeclampsia","volume":"4","author":"Landi","year":"2014","journal-title":"World J. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.preghy.2019.05.015_b0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2702.2006.01438.x","article-title":"A comparison of HIV positive and negative pregnant women at a public sector hospital in South Africa","volume":"15","author":"Bodkin","year":"2006","journal-title":"J. Clin. Nurs."},{"issue":"4","key":"10.1016\/j.preghy.2019.05.015_b0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.preghy.2016.04.006","article-title":"Antiretrovirals causing severe pre-eclampsia","volume":"6","author":"Tooke","year":"2016","journal-title":"Pregnancy Hypertens."},{"issue":"14","key":"10.1016\/j.preghy.2019.05.015_b0120","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/01.aids.0000244201.11006.1c","article-title":"Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994\u20132003","volume":"20","author":"Kourtis","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.preghy.2019.05.015_b0125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jinf.2013.12.018","article-title":"Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries","volume":"68","author":"Machado","year":"2014","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.preghy.2019.05.015_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.05.048","article-title":"Trends in hospitalizations of pregnant HIV-infected womenin the United States: 2004 through 2011","volume":"215","author":"Ewing","year":"2016","journal-title":"Am. J. Obstet Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2019.05.015_b0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijgo.2016.03.014","article-title":"A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia","volume":"134","author":"Stoner","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","article-title":"The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery","volume":"114","author":"Boer","year":"2007","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0145","article-title":"Maternal outcomes following introduction of antiretroviral therapy in the public sector: a prospective study at a tertiary hospital in the Eastern Cape","volume":"15","author":"Bera","year":"2009","journal-title":"S. Afr. J. Obstet Gynaecol."},{"issue":"8","key":"10.1016\/j.preghy.2019.05.015_b0150","doi-asserted-by":"crossref","DOI":"10.7196\/SAMJ.6590","article-title":"Maternal and fetal outcomes of HIV-infected and non-infected pregnant women admitted to two intensive care units in Pietermaritzburg, South Africa","volume":"103","author":"Ngene","year":"2013","journal-title":"S. Afr. Med. J."},{"issue":"3","key":"10.1016\/j.preghy.2019.05.015_b0155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijgo.2016.03.023","article-title":"Association of HIV and highly active antiretroviral therapy with clinical and biochemical indices among women with pre-eclampsia","volume":"134","author":"Maharaj","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","article-title":"Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy","volume":"20","author":"Suy","year":"2006","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.preghy.2019.05.015_b0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijgo.2011.04.008","article-title":"Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana","volume":"115","author":"Parekh","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"5","key":"10.1016\/j.preghy.2019.05.015_b0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/QAI.0b013e318286d77e","article-title":"High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma bana study, Botswana","volume":"62","author":"Powis","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijgo.12038","article-title":"Associations between HIV, highly active anti-retroviral therapy, and hypertensive disorders of pregnancy among maternal deaths in South Africa 2011\u20132013","volume":"136","author":"Sebitloane","year":"2017","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031580","article-title":"High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana","volume":"7","author":"Shapiro","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2004.04.014","article-title":"Preeclampsia and HIV infection","volume":"117","author":"Mattar","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.preghy.2019.05.015_b0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0029-7844(99)00526-8","article-title":"Combination antiretroviral therapy in human immunodeficiency virus\u2013infected pregnant women","volume":"94","author":"McGowan","year":"1999","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.08.020","article-title":"Pregnancy outcomes in young women with perinatally acquired human immunodeficiency virus-1","volume":"200","author":"Williams","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5 Pt 1","key":"10.1016\/j.preghy.2019.05.015_b0200","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0029-7844(99)00526-8","article-title":"Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women","volume":"94","author":"McGowan","year":"1999","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2019.05.015_b0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jash.2015.01.007","article-title":"Incidence of primary hypertension in a population-based cohort of HIV-infected compared with non-HIV-infected persons and the effect of combined antiretroviral therapy","volume":"9","author":"Tripathi","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"issue":"6","key":"10.1016\/j.preghy.2019.05.015_b0210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.placenta.2010.03.014","article-title":"Proteases and sFlt-1 release in the human placenta","volume":"31","author":"Zhao","year":"2010","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QAI.0000000000000131","article-title":"Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir\/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE)","volume":"66","author":"Shaffer","year":"2014","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"issue":"2","key":"10.1016\/j.preghy.2019.05.015_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"17","key":"10.1016\/j.preghy.2019.05.015_b0225","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.preghy.2019.05.015_b9000","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/jpm.2010.052","article-title":"Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003\u20132008","volume":"38","author":"Aebi-Popp","year":"2010","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.preghy.2019.05.015_b9005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/hiv.12142","article-title":"Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort","volume":"15","author":"Reitter","year":"2014","journal-title":"HIV Med."},{"key":"10.1016\/j.preghy.2019.05.015_b9010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and little maternal toxicity are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy","volume":"38","author":"Tuomala","year":"2005","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"10.1016\/j.preghy.2019.05.015_b9015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jogc.2015.10.013","article-title":"A ten-year review of antenatal complications and pregnancy outcomes among HIV-positive pregnant women","volume":"38","author":"Yudin","year":"2016","journal-title":"J. Obstet. Gynaecol. Can."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778918307669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778918307669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:51:29Z","timestamp":1761897089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778918307669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":49,"alternative-id":["S2210778918307669"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2019.05.015","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2019.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}